510(k) K231214
K231214 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON VZV IgG HT, LIAISON Control VZV IgG HT". The FDA issued a decision of Substantially Equivalent on October 27, 2023. The device falls under product code LFY (Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster), a Class II device regulated under 21 CFR 866.3900. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 27, 2023
- Date Received
- April 28, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster
- Device Class
- Class II
- Regulation Number
- 866.3900
- Review Panel
- MI
- Submission Type